Company Profile: Genetic Signatures Limited (ASX: GSS) is in Pharmaceuticals, Biotechnology, and Life Sciences industry. The company mainly operates as a molecular diagnostic company and has developed a wide range of products for the detection of infectious diseases. Some of these products are EasyScreen™ Multiplex Real-Time PCR Pathogen Detection Kits, 3base™ Technology. The EasyScreen products are used to provide hospital and pathology laboratories with the molecular tools. These molecular tools, however, are used for screening a wide array of infectious pathogens in a rapid environment. It was founded in 2001 by Dr. Geoffrey Grigg and was admitted to the Official List of the ASX on 31 March 2015 as a healthcare company.